GDF3 and breast neoplasm: In support of this evidence, recently it is revealed that GDF3 expression was limited to 7.7% (9/117) of primary breast tumor samples and was correlated with the absence of axillary lymph node metastasis, suggesting a protective effect of GDF3 [25].